A new Northwestern Medicine study has discovered coffee changes many more metabolites in the blood than previously known, including those in the endocannabinoid system.
A groundbreaking new wearable device developed by Northwestern scientists and designed to be worn on the throat could be a game-changer in the field of stroke rehabilitation.
Northwestern Medicine scientists have discovered why Huntington’s disease is so toxic to cancer cells and have harnessed it for a novel approach to treat cancer.
A genetic change in a “clock gene” produced significant changes in circadian rhythm, providing insight into how the complex system is regulated according to a study published in PNAS.
An emergency thrombectomy, which surgically removes large blood clots, may be beneficial in far more stroke patients than previously thought, according to a new trial.
Northwestern Medicine scientists uncovered the molecular process behind a buildup of toxic proteins in Parkinson’s patients, a discovery that may lead to improved therapies.
For the first time, Northwestern Medicine scientists have discovered that two key cellular structures, mitochondria and lysosomes, are in direct contact with each other.
A team from the academic and clinical arms of
Northwestern Medicine has been assembled to study patient DNA and create customized therapies for Parkinson’s, Epilepsy, and ALS in a model called Personalized Neurology.
A device attached to a patient’s scalp that delivers a continuous dose of low-intensity electric fields improves survival and slows the growth of a deadly brain tumor, according to a new trial.
A new study provides insights into a mechanism underlying Parkinson’s disease and suggests that an existing drug could be employed as a novel treatment.